From: Is the thymidine labeling index a good prognostic marker in breast cancer?
All patients | Patients with TLI-low | Patients with TLI-high | p-value | ||||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Age | 0.900 | ||||||
≤50 years | 136 | 50.7 | 52 | 38.2 | 84 | 61.8 | |
>50 years | 132 | 49.3 | 52 | 39.4 | 80 | 60.6 | |
Menopausal status | 0.559 | ||||||
Premenopausal | 105 | 39.5 | 38 | 36.2 | 67 | 63.8 | |
Postmenopausal | 161 | 60.5 | 64 | 39.8 | 97 | 60.2 | |
Tumor | 0.306 | ||||||
pT1 | 103 | 38.4 | 44 | 42.7 | 59 | 57.3 | |
pT2+pT3+pT4 | 165 | 61.6 | 60 | 36.4 | 105 | 63.6 | |
Node | 0.448 | ||||||
pN0 | 114 | 42.5 | 41 | 36.0 | 73 | 64.0 | |
pN(+) | 154 | 57.5 | 63 | 40.9 | 91 | 59.1 | |
Stage | 0.596 | ||||||
I | 54 | 20.1 | 18 | 33.3 | 36 | 66.7 | |
II | 138 | 51.5 | 54 | 39.1 | 84 | 60.9 | |
III | 76 | 28.4 | 32 | 42.1 | 44 | 57.9 | |
Type of surgery | 0.330 | ||||||
Breast conservation | 86 | 32.1 | 37 | 43.0 | 49 | 57.0 | |
Mastectomy | 182 | 67.9 | 67 | 36.8 | 115 | 63.2 | |
Radiation therapy | 0.911 | ||||||
Yes | 200 | 74.6 | 78 | 39.0 | 122 | 61.0 | |
No | 68 | 25.4 | 26 | 38.2 | 42 | 61.8 | |
Hormonal Therapy | 0.021 | ||||||
Yes | 187 | 69.8 | 81 | 43.3 | 106 | 56.7 | |
No | 81 | 30.2 | 23 | 28.4 | 58 | 71.6 | |
Chemotherapy | 0.451 | ||||||
Yes | 205 | 76.5 | 77 | 37.6 | 128 | 62.4 | |
No | 63 | 23.5 | 27 | 42.9 | 36 | 57.1 |